Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Narayan Dutt

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Emerging Infectious Diseases|December 27, 2022
Multicenter Case-Control Study of COVID-19-Associated Mucormycosis Outbreak, IndiaValliappan Muthu, Ritesh Agarwal, Shivaprakash Mandya Rudramurthy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 11, 2023
Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicentre retrospective study from IndiaValliappan Muthu, Ritesh Agarwal, Shivaprakash Mandya Rudramurthy, et al.
Mycoses|May 20, 2024
Prevalence of co-existent COVID-19-associated pulmonary aspergillosis (CAPA) and its impact on early mortality in patients with COVID-19-associated pulmonary mucormycosis (CAPM)Valliappan Muthu, Ritesh Agarwal, Shivaprakash Mandya Rudramurthy, et al.
Lung India : Official Organ of Indian Chest Society|April 30, 2024
Computed tomography findings of COVID-19-associated pulmonary mucormycosis: Data from a multicenter retrospective study (Mucovi2), IndiaValliappan Muthu, Ritesh Agarwal, Shivaprakash Mandya Rudramurthy, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Emerging Infectious Diseases|December 27, 2022
Multicenter Case-Control Study of COVID-19-Associated Mucormycosis Outbreak, IndiaValliappan Muthu, Ritesh Agarwal, Shivaprakash Mandya Rudramurthy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 11, 2023
Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicentre retrospective study from IndiaValliappan Muthu, Ritesh Agarwal, Shivaprakash Mandya Rudramurthy, et al.
Mycoses|May 20, 2024
Prevalence of co-existent COVID-19-associated pulmonary aspergillosis (CAPA) and its impact on early mortality in patients with COVID-19-associated pulmonary mucormycosis (CAPM)Valliappan Muthu, Ritesh Agarwal, Shivaprakash Mandya Rudramurthy, et al.
Lung India : Official Organ of Indian Chest Society|April 30, 2024
Computed tomography findings of COVID-19-associated pulmonary mucormycosis: Data from a multicenter retrospective study (Mucovi2), IndiaValliappan Muthu, Ritesh Agarwal, Shivaprakash Mandya Rudramurthy, et al.
Pageof 3